Your browser doesn't support javascript.
loading
Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
Alexander, Tobias; Cheng, Qingyu; Klotsche, Jens; Khodadadi, Laleh; Waka, Aderajew; Biesen, Robert; Hoyer, Bimba F; Burmester, Gerd R; Radbruch, Andreas; Hiepe, Falk.
Afiliación
  • Alexander T; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Germany.
  • Cheng Q; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Autoimmunology Group, Berlin, Germany.
  • Klotsche J; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Germany.
  • Khodadadi L; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Autoimmunology Group, Berlin, Germany.
  • Waka A; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Epidemiology Group, Berlin, Germany.
  • Biesen R; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Germany.
  • Hoyer BF; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Autoimmunology Group, Berlin, Germany.
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Germany.
  • Radbruch A; German Rheumatism Research Center (DRFZ), a Leibniz Institute, Autoimmunology Group, Berlin, Germany.
  • Hiepe F; Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Germany.
Eur J Immunol ; 48(9): 1573-1579, 2018 09.
Article en En | MEDLINE | ID: mdl-29979809

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Autoanticuerpos / Complejo de la Endopetidasa Proteasomal / Células Precursoras de Linfocitos B / Células Precursoras de Linfocitos T / Inhibidores de Proteasoma / Bortezomib / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Autoanticuerpos / Complejo de la Endopetidasa Proteasomal / Células Precursoras de Linfocitos B / Células Precursoras de Linfocitos T / Inhibidores de Proteasoma / Bortezomib / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania